AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 HTG Molecular DiagnosticsBioNano GenomicsArrayitAethlon MedicalScientific Industries
SymbolNASDAQ:HTGMNASDAQ:BNGOOTCMKTS:ARYCNASDAQ:AEMDOTCMKTS:SCND
Price Information
Current Price$0.63$0.48$0.01$1.42$6.33
52 Week RangeBuyBuyN/AN/AN/A
Beat the Market™ Rank
Overall Score1.31.30.70.80.5
Analysis Score3.43.50.00.00.0
Community Score2.72.32.42.72.6
Dividend Score0.00.00.00.00.0
Ownership Score0.00.01.00.00.0
Earnings & Valuation Score0.60.60.01.30.0
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/AN/A
Consensus Price Target$1.18$2.25N/AN/AN/A
% Upside from Price Target85.36% upside369.83% upsideN/AN/AN/A
Trade Information
Market Cap$32.67 million$22.25 million$12.39 million$13.77 million$9.51 million
Beta1.781.5-0.570.730.2
Average Volume1,933,0884,699,8611,183,4711,453,953583
Sales & Book Value
Annual Revenue$19.20 million$10.13 millionN/A$230,000.00$10.20 million
Price / Sales2.052.42N/A57.820.93
CashflowN/AN/AN/AN/A$0.60 per share
Price / CashN/AN/AN/AN/A10.47
Book Value$0.41 per share$0.11 per shareN/A$1.82 per share$4.24 per share
Price / Book1.554.35N/A0.781.49
Profitability
Net Income$-19,300,000.00$-29,820,000.00N/A$-6,200,000.00$650,000.00
EPS($0.51)($1.90)N/A($5.10)N/A
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-106.35%-294.32%N/AN/A-0.78%
Return on Equity (ROE)-90.50%-15,207.37%N/A-349.11%-1.20%
Return on Assets (ROA)-44.79%-110.94%N/A-191.49%-0.86%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.33%N/AN/A0.02%0.14%
Current Ratio4.61%1.07%N/A5.31%3.73%
Quick Ratio4.42%0.94%N/A5.31%1.94%
Ownership Information
Institutional Ownership Percentage28.69%2.97%N/A3.07%N/A
Insider Ownership Percentage4.60%1.20%58.00%4.00%32.70%
Miscellaneous
Employees107777630
Shares Outstanding62.21 million51.17 million1.13 billion9.37 million1.50 million
Next Earnings Date8/4/2020 (Estimated)6/18/2020 (Confirmed)N/A7/6/2020 (Estimated)10/2/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.